IRE: Gefitinib

IRE is a Ligand Of Interest in 2ITY designated by the RCSB


Best-fitted instance in this entry
Other instances in this entry
Best-fitted instance in this entry
Best-fitted PDB instances with same target (top 5)
Best-fitted instance in this entry
Best-fitted PDB instances with different target (top 5)
IdentifierRanking for goodness of fit Ranking for geometry Real space R factor Real space correlation coefficient RMSZ-bond-length RMSZ-bond-angleOutliers of bond length Outliers of bond angle Atomic clashesStereochemical errorsModel completenessAverage occupancy
2ITY_IRE_A_2020 6% 19% 0.34 0.7821.75 1.7 4 1050100%1
4I22_IRE_A_9001 85% 28% 0.104 0.9681.75 1.18 9 210100%1
4WKQ_IRE_A_1101 44% 17% 0.163 0.891.63 2.01 6 1010100%1
3UG2_IRE_A_1 29% 15% 0.24 0.8981.24 2.46 4 1720100%0.5
2ITZ_IRE_A_2021 21% 22% 0.254 0.8631.39 1.85 2 1230100%1
2ITO_IRE_A_2020 6% 22% 0.347 0.7911.34 1.88 3 1030100%1
5Y80_IRE_A_401 45% 11% 0.184 0.9171.73 2.45 10 18 20100%1
5Y7Z_IRE_A_401 36% 10% 0.226 0.9191.82 2.46 10 1710100%1